$MU
Micron Technology Inc Stock $mu

$mu Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000072312521000012 Filed on January 08, 2021

Income Statement

Concept	2020 Q4	2019 Q4
Revenue	$5.773B	$5.144B
YoY Change	12.23%	-34.99%
Cost Of Revenue	$4.037B	$3.778B
YoY Change	6.86%	14.55%
Gross Profit	$1.736B	$1.366B
YoY Change	27.09%	-70.4%
Gross Profit Margin	30.07%	26.56%
Selling, General & Admin	$214.0M	$211.0M
YoY Change	1.42%	0.96%
% of Gross Profit	12.33%	15.45%
Research & Development	$647.0M	$640.0M
YoY Change	1.09%	4.75%
% of Gross Profit	37.27%	46.85%
Depreciation & Amortization	$1.487B	$1.296B
YoY Change	14.74%	-2.92%
% of Gross Profit	85.66%	94.88%
Operating Expenses	$861.0M	$851.0M
YoY Change	1.18%	3.78%
Operating Profit	$866.0M	$518.0M
YoY Change	67.18%	-86.22%
Interest Expense	$48.00M	$47.00M
YoY Change	2.13%	42.42%
% of Operating Profit	5.54%	9.07%
Other Income/Expense, Net	$13.00M	$46.00M
YoY Change	-71.74%	411.11%
Pretax Income	$841.0M	$561.0M
YoY Change	49.91%	-85.13%
Income Tax	$51.00M	$55.00M
% Of Pretax Income	6.06%	9.8%
Net Earnings	$803.0M	$491.0M
YoY Change	63.54%	-85.09%
Net Earnings / Revenue	13.91%	9.55%
Basic Earnings Per Share	$0.72	$0.44
Diluted Earnings Per Share	$0.71	$0.43
COMMON SHARES
Basic Shares Outstanding	1.115B shares	1.107B shares
Diluted Shares Outstanding	1.135B shares	1.129B shares

Balance Sheet

Concept	2020 Q4	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.032B	$7.588B
YoY Change	-7.33%	36.4%
Cash & Equivalents	$5.985B	$6.969B
Short-Term Investments	$1.047B	$619.0M
Other Short-Term Assets	$285.0M	$217.0M
YoY Change	31.34%	19.23%
Inventory	$5.521B	$4.943B
Prepaid Expenses
Receivables	$3.182B	$3.030B
Other Receivables	$214.0M	$195.0M
Total Short-Term Assets	$16.53B	$16.17B
YoY Change	2.24%	7.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.81B	$29.35B
YoY Change	11.77%	18.32%
Goodwill	$1.228B	$1.228B
YoY Change	0.0%	0.0%
Intangibles	$336.0M	$333.0M
YoY Change	0.9%	-6.46%
Long-Term Investments	$1.264B	$599.0M
YoY Change	111.02%	-61.73%
Other Assets	$802.0M	$579.0M
YoY Change	38.51%	-23.61%
Total Long-Term Assets	$37.16B	$33.48B
YoY Change	10.99%	13.28%
TOTAL ASSETS
Total Short-Term Assets	$16.53B	$16.17B
Total Long-Term Assets	$37.16B	$33.48B
Total Assets	$53.69B	$49.65B
YoY Change	8.14%	11.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.656B	$1.879B
YoY Change	-11.87%	11.65%
Accrued Expenses	$636.0M	$557.0M
YoY Change	14.18%	1.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$273.0M	$462.0M
YoY Change	-40.91%	16.08%
Total Short-Term Liabilities	$5.688B	$6.317B
YoY Change	-9.96%	21.74%
LONG-TERM LIABILITIES
Long-Term Debt	$6.356B	$5.188B
YoY Change	22.51%	38.87%
Other Long-Term Liabilities	$555.0M	$426.0M
YoY Change	30.28%	-48.92%
Total Long-Term Liabilities	$555.0M	$426.0M
YoY Change	30.28%	-48.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.688B	$6.317B
Total Long-Term Liabilities	$555.0M	$426.0M
Total Liabilities	$13.78B	$13.05B
YoY Change	5.62%	33.76%
SHAREHOLDERS EQUITY
Retained Earnings	$34.14B	$31.22B
YoY Change	9.35%	12.42%
Common Stock	$9.154B	$8.547B
YoY Change	7.1%	0.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.91B	$36.50B
YoY Change
Total Liabilities & Shareholders Equity	$53.69B	$49.65B
YoY Change	8.14%	11.33%

Cashflow Statement

Concept	2020 Q4	2019 Q4
OPERATING ACTIVITIES
Net Income	$803.0M	$491.0M
YoY Change	63.54%	-85.09%
Depreciation, Depletion And Amortization	$1.487B	$1.296B
YoY Change	14.74%	-2.92%
Cash From Operating Activities	$1.967B	$2.011B
YoY Change	-2.19%	-58.19%
INVESTING ACTIVITIES
Capital Expenditures	$2.738B	$1.943B
YoY Change	40.92%	-28.04%
Acquisitions
YoY Change
Other Investing Activities	-$21.00M	$12.00M
YoY Change	-275.0%	-77.36%
Cash From Investing Activities	-$3.418B	-$1.189B
YoY Change	187.47%	-73.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$89.00M
YoY Change	-100.0%	-95.15%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$214.0M	-$992.0M
YoY Change	-78.43%	-59.26%
NET CHANGE
Cash From Operating Activities	$1.967B	$2.011B
Cash From Investing Activities	-$3.418B	-$1.189B
Cash From Financing Activities	-$214.0M	-$992.0M
Net Change In Cash	-$1.638B	-$184.0M
YoY Change	790.22%	-91.08%
FREE CASH FLOW
Cash From Operating Activities	$1.967B	$2.011B
Capital Expenditures	$2.738B	$1.943B
Free Cash Flow	-$771.0M	$68.00M
YoY Change	-1233.82%	-96.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000723125
CY2020Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-02
CY2020Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2020Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q4	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	dei	Document Type DocumentType	10-Q
CY2019Q4	us-gaap	Profit Loss ProfitLoss	508000000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	40000000	USD
CY2020Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q4	dei	Document Period End Date DocumentPeriodEndDate	2020-12-03
CY2020Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q4	dei	Entity File Number EntityFileNumber	1-10658
CY2020Q4	dei	Entity Registrant Name EntityRegistrantName	Micron Technology, Inc.
CY2020Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-1618004
CY2020Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	8000 S. Federal Way
CY2020Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Boise
CY2020Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
CY2020Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83716
CY2020Q4	dei	City Area Code CityAreaCode	208
CY2020Q4	dei	Local Phone Number LocalPhoneNumber	368-4000
CY2020Q4	dei	Security12b Title Security12bTitle	Common Stock, par value $0.10 per share
CY2020Q4	dei	Trading Symbol TradingSymbol	MU
CY2020Q4	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q4	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1118671492	shares
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5773000000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5144000000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4037000000	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3778000000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	1736000000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	1366000000	USD
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	647000000	USD
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	640000000	USD
CY2020Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	214000000	USD
CY2019Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	211000000	USD
CY2020Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-9000000	USD
CY2019Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3000000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	866000000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	518000000	USD
CY2020Q4	us-gaap	Investment Income Net InvestmentIncomeNet	10000000	USD
CY2019Q4	us-gaap	Investment Income Net InvestmentIncomeNet	44000000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	48000000	USD
CY2019Q4	us-gaap	Interest Expense InterestExpense	47000000	USD
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000000	USD
CY2019Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	46000000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	841000000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	561000000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51000000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55000000	USD
CY2020Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	13000000	USD
CY2019Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2000000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	803000000	USD
CY2019Q4	us-gaap	Profit Loss ProfitLoss	508000000	USD
CY2020Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17000000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	803000000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	491000000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1115000000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1107000000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1135000000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1129000000	shares
CY2020Q4	us-gaap	Profit Loss ProfitLoss	803000000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	3000000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-5000000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1000000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	39000000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3000000	USD
CY2020Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	842000000	USD
CY2019Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	505000000	USD
CY2020Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2019Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	17000000	USD
CY2020Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	842000000	USD
CY2019Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	488000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5985000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7624000000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1047000000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	518000000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3691000000	USD
CY2020Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	3912000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	5521000000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	5607000000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	285000000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	304000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	16529000000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	17965000000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1264000000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1048000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	32229000000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	31031000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	577000000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	584000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	336000000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	334000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	726000000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	707000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1228000000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	1228000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	802000000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	781000000	USD
CY2020Q4	us-gaap	Assets Assets	53691000000	USD
CY2020Q3	us-gaap	Assets Assets	53678000000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4856000000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5817000000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	273000000	USD
CY2020Q3	us-gaap	Debt Current DebtCurrent	270000000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	559000000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	548000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5688000000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6635000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6356000000	USD
CY2020Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6373000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	529000000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	533000000	USD
CY2020Q4	mu	Unearned Government Incentives Noncurrent UnearnedGovernmentIncentivesNoncurrent	656000000	USD
CY2020Q3	mu	Unearned Government Incentives Noncurrent UnearnedGovernmentIncentivesNoncurrent	643000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	555000000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	498000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	13784000000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	14682000000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1198000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1117000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1194000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1113000000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	120000000	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	119000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9034000000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8917000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34138000000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	33384000000	USD
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81000000	shares
CY2020Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81000000	shares
CY2020Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3495000000	USD
CY2020Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3495000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	110000000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	71000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	39907000000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	38996000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53691000000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53678000000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	38996000000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	803000000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	39000000	USD
CY2020Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	34000000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92000000	USD
CY2020Q4	mu	Treasury Shares Acquired And Stock Repurchased And Retired TreasurySharesAcquiredAndStockRepurchasedAndRetired	57000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	39907000000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36770000000	USD
CY2019Q4	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	506000000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3000000	USD
CY2019Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	32000000	USD
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72000000	USD
CY2019Q4	mu	Treasury Shares Acquired And Stock Repurchased And Retired TreasurySharesAcquiredAndStockRepurchasedAndRetired	90000000	USD
CY2019Q4	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	781000000	USD
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	6000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36500000000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	803000000	USD
CY2019Q4	us-gaap	Profit Loss ProfitLoss	508000000	USD
CY2020Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1487000000	USD
CY2019Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1296000000	USD
CY2020Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7000000	USD
CY2019Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	10000000	USD
CY2020Q4	us-gaap	Share Based Compensation ShareBasedCompensation	92000000	USD
CY2019Q4	us-gaap	Share Based Compensation ShareBasedCompensation	72000000	USD
CY2020Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	42000000	USD
CY2020Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-251000000	USD
CY2019Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	208000000	USD
CY2020Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-86000000	USD
CY2019Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-175000000	USD
CY2020Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-753000000	USD
CY2019Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	178000000	USD
CY2020Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	24000000	USD
CY2019Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-19000000	USD
CY2020Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	18000000	USD
CY2019Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3000000	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1967000000	USD
CY2019Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2011000000	USD
CY2020Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2738000000	USD
CY2019Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1943000000	USD
CY2020Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1002000000	USD
CY2019Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	407000000	USD
CY2020Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	216000000	USD
CY2019Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	163000000	USD
CY2020Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	45000000	USD
CY2019Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	988000000	USD
CY2020Q4	mu	Proceeds From Government Incentives ProceedsFromGovernmentIncentives	40000000	USD
CY2019Q4	mu	Proceeds From Government Incentives ProceedsFromGovernmentIncentives	22000000	USD
CY2020Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-21000000	USD
CY2019Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	12000000	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3418000000	USD
CY2019Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1189000000	USD
CY2020Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	97000000	USD
CY2019Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	11000000	USD
CY2020Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	84000000	USD
CY2019Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	1415000000	USD
CY2020Q4	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2019Q4	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	744000000	USD
CY2020Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2019Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1250000000	USD
CY2020Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-33000000	USD
CY2019Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-72000000	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-214000000	USD
CY2019Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-992000000	USD
CY2020Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27000000	USD
CY2019Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1638000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-184000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7690000000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7279000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6052000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7095000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5985000000	USD
CY2020Q4	us-gaap	Basis Of Accounting BasisOfAccounting	<div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended September 3, 2020. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal 2021 contains 52 weeks and our fiscal 2020 contained 53 weeks. The first quarters of fiscal 2021 and 2020 each contained 13 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended September 3, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through October 31, 2019, IMFT was a consolidated variable interest entity. We acquired Intel’s noncontrolling interest in IMFT on October 31, 2019, at which time IMFT, now known as MTU, became a wholly-owned subsidiary.</span></div>
CY2020Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
CY2020Q4	us-gaap	Fiscal Period FiscalPeriod	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal 2021 contains 52 weeks and our fiscal 2020 contained 53 weeks. The first quarters of fiscal 2021 and 2020 each contained 13 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended September 3, 2020.
CY2020Q4	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 – </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options and Derivatives and Hedging - Contracts in Entity’s Own Equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. This ASU requires a convertible debt instrument to be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and </span></div>recognition as derivatives. This ASU requires an entity to use the if-converted method in the diluted earnings per share calculation for convertible instruments. This ASU will be effective for us in the first quarter of 2023, with early adoption permitted beginning in the first quarter of 2022, and permits the use of either the modified retrospective or fully retrospective method of transition. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1047000000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1264000000	USD
CY2020Q4	mu	Cash Cash Equivalentsand Availablefor Sale Debt Securities CashCashEquivalentsandAvailableforSaleDebtSecurities	8296000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7624000000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	518000000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1048000000	USD
CY2020Q3	mu	Cash Cash Equivalentsand Availablefor Sale Debt Securities CashCashEquivalentsandAvailableforSaleDebtSecurities	9190000000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	67000000	USD
CY2020Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	66000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6052000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7690000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3182000000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3494000000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	295000000	USD
CY2020Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	232000000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	214000000	USD
CY2020Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	186000000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3691000000	USD
CY2020Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	3912000000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	878000000	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1001000000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3878000000	USD
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3854000000	USD
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	765000000	USD
CY2020Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	752000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	5521000000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	5607000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	67823000000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	65331000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	35594000000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	34300000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	32229000000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	31031000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	628000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	292000000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	616000000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	282000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1228000000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	1228000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	22000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	12000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	57000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	60000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	53000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	47000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	26000000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	16000000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	40000000	USD
CY2020Q4	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	5000000	USD
CY2019Q4	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	6000000	USD
CY2020Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	27000000	USD
CY2019Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	24000000	USD
CY2020Q4	us-gaap	Lease Cost LeaseCost	48000000	USD
CY2019Q4	us-gaap	Lease Cost LeaseCost	70000000	USD
CY2020Q4	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	6000000	USD
CY2019Q4	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	6000000	USD
CY2020Q4	mu	Operating Lease Payments Net Of Tenant Improvement Receipts OperatingLeasePaymentsNetOfTenantImprovementReceipts	27000000	USD
CY2019Q4	mu	Operating Lease Payments Net Of Tenant Improvement Receipts OperatingLeasePaymentsNetOfTenantImprovementReceipts	17000000	USD
CY2020Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	21000000	USD
CY2019Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	64000000	USD
CY2020Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	61000000	USD
CY2019Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7000000	USD
CY2019Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	13000000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	471000000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	426000000	USD
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0413
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0451
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0266
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0267
CY2020Q4	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	71000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	53000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	97000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	71000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	85000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	67000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	59000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	59000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	44000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	48000000	USD
CY2020Q4	mu	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	282000000	USD
CY2020Q4	mu	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	402000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	107000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	116000000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	531000000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	584000000	USD
CY2020Q4	mu	Lessee Operating Lease Lease Not Yet Commenced Future Payments LesseeOperatingLeaseLeaseNotYetCommencedFuturePayments	152000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P10Y
CY2020Q4	mu	Lessee Operating Lease Lease Not Yet Commenced Lock In Period LesseeOperatingLeaseLeaseNotYetCommencedLockInPeriod	P3Y
CY2020Q4	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Renewal Term1 LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1	P10Y
CY2020Q4	mu	Lessee Finance Lease Lease Not Yet Commenced Future Payments LesseeFinanceLeaseLeaseNotYetCommencedFuturePayments	812000000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1656000000	USD
CY2020Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2191000000	USD
CY2020Q4	mu	Property Plant And Equipment Payable Current PropertyPlantAndEquipmentPayableCurrent	2180000000	USD
CY2020Q3	mu	Property Plant And Equipment Payable Current PropertyPlantAndEquipmentPayableCurrent	2374000000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	636000000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	849000000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	180000000	USD
CY2020Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	237000000	USD
CY2020Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	204000000	USD
CY2020Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	166000000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4856000000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5817000000	USD
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0413
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	78000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	453000000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	531000000	USD
CY2020Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	76000000	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	410000000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	486000000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	273000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6356000000	USD
CY2020Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6629000000	USD
CY2020Q3	us-gaap	Debt Current DebtCurrent	270000000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	62000000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	5000000	USD
CY2020Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	45000000	USD
CY2020Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3000000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	71000000	shares
CY2020Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92000000	USD
CY2019Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	72000000	USD
CY2020Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92000000	USD
CY2019Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	72000000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	891000000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5773000000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5144000000	USD
CY2020Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	56000000	USD
CY2020Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.05
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	67000000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	65000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	41000000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	413000000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.87
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.13
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	480000000	USD
CY2020Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	466000000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	803000000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	491000000	USD
CY2020Q4	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	0	USD
CY2019Q4	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	42000000	USD
CY2020Q4	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	13000000	USD
CY2019Q4	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	4000000	USD
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000000	USD
CY2019Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	46000000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	841000000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	561000000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51000000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	415000000	USD
CY2020Q4	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2020Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6373000000	USD
CY2020Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6643000000	USD
CY2020Q4	us-gaap	Share Price SharePrice	69.90
CY2020Q4	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div><span style="color:#0090da;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Patent Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2014, MLC Intellectual Property, LLC filed a patent infringement action against Micron in the U.S. District Court for the Northern District of California. The complaint alleges that Micron infringes a single U.S. patent and seeks damages, attorneys’ fees, and costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2014, Elm 3DS Innovations, LLC (“Elm”) filed a patent infringement action against Micron; Micron Semiconductor Products, Inc.; and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe 13 U.S. patents and seeks damages, attorneys’ fees, and costs.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 15, 2014, Innovative Memory Solutions, Inc. (“IMS”) filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe eight U.S. patents and seeks damages, attorneys’ fees, and costs. Subsequently, six patents were invalidated or withdrawn, leaving two asserted patents in the District Court.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 19, 2018, Micron Semiconductor (Xi’an) Co., Ltd. (“MXA”) was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. (“Jinhua”) in the Fuzhou Intermediate People’s Court in Fujian Province, China (the “Fuzhou Court”). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. (“MSS”) was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 98 million Chinese yuan plus court fees incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation (“UMC”) in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 90 million Chinese yuan plus court fees incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and two additional complaints filed by UMC in the Fuzhou Court. The three additional complaints allege that MSS infringes three Chinese patents by manufacturing and selling certain Crucial MX300 SSDs and certain GDDR5 memory chips. The two complaints filed by UMC each seek an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages for each complaint of 90 million Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 98 million Chinese yuan plus court fees incurred. On October 9, 2018, UMC withdrew its complaint that alleged MSS infringed a Chinese patent by manufacturing and selling certain GDDR5 memory chips.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistix-branded DRAM modules and solid-state drives in China. The affected products made up slightly more than 1% of our annualized revenue in 2018. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 4, 2020, Flash-Control, LLC (“Flash-Control”) filed a patent infringement action against Micron in the U.S. District Court for the Western District of Texas. The complaint alleges that four U.S. patents are infringed by unspecified DDR4 SDRAM, NVRDIMM, NVDIMM, 3D XPoint</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or SSD products that incorporate memory controllers and flash memory. The complaint seeks damages, attorneys’ fees, and costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for substantially all of our revenue.</span></div><div><span><br/></span></div><div><span style="color:#0090da;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Qimonda</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda’s insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V. (“Micron B.V.”), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda’s shares of Inotera (the “Inotera Shares”), representing approximately 18% of Inotera’s outstanding shares at that time, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda’s claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda’s obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments had no immediate, enforceable effect and Micron, accordingly, has been able to continue to operate with full control of the Inotera Shares subject to further developments in the case. On April 17, 2014, Micron and Micron B.V. filed a notice of appeal with the German Appeals Court challenging the District Court’s decision. After opening briefs, the Appeals Court held a hearing on the matter on July 9, 2015, and thereafter appointed an independent expert to perform an evaluation of Dr. Jaffé’s claims that the amount Micron paid for Qimonda was less than fair market value. On January 25, 2018, the court-appointed expert issued a report concluding that the amount paid by Micron was within an acceptable fair-value range. The Appeals Court held a subsequent hearing on April 30, 2019, and on May 28, 2019, the Appeals Court remanded the case to the expert for supplemental expert opinion. On March 31, 2020, the expert presented a revised opinion to the Appeals Court which reaffirmed the earlier view that the amount paid by Micron was still within an acceptable range of fair value.</span></div><div><span><br/></span></div><div><span style="color:#0090da;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Antitrust Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently, two substantially identical cases were filed in the same court. The lawsuits purported to be on behalf of a nationwide class of indirect purchasers of DRAM products. On September 3, 2019, the District Court granted Micron’s motion to dismiss and allowed the plaintiffs the opportunity to file a consolidated, amended complaint. On October 28, 2019, the plaintiffs filed a consolidated amended complaint that purported to be on behalf of a nationwide class of indirect purchasers of DRAM products. The amended complaint asserted claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to at least February 1, 2018, and sought treble monetary damages, costs, interest, attorneys’ fees, and other injunctive and equitable relief. On December 21, 2020, the District Court dismissed the plaintiffs’ claims and entered judgment against them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently, four substantially identical cases were filed in the same court. On October 28, 2019, the plaintiffs filed a consolidated, amended complaint. The consolidated complaint purports to be on behalf of a nationwide class of direct purchasers of DRAM products. The consolidated complaint asserts claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 through at least February 1, 2018, and seeks treble monetary damages, costs, interest, attorneys’ fees, and other injunctive and equitable relief. On December 21, 2020, the District Court granted Micron’s motion to dismiss and granted the plaintiffs permission to file an amended complaint.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, six cases have been filed in the following Canadian courts: Superior Court of Quebec, the Federal Court of Canada, the Ontario Superior Court of Justice, and the Supreme Court of British Columbia. The substantive allegations in these cases are similar to those asserted in the cases filed in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2018, the Chinese State Administration for Market Regulation (“SAMR”) notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation.</span></div><div><span style="color:#0090da;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Matter</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 5, 2019, a derivative complaint was filed by a shareholder against certain current and former officers and directors of Micron, allegedly on behalf of and for the benefit of Micron, in the U.S. District Court for the District of Delaware alleging securities fraud, breaches of fiduciary duties, and other violations of law involving misrepresentations about purported anticompetitive behavior in the DRAM industry. The complaint seeks damages, fees, interest, costs, and other appropriate relief.</span></div><div><span><br/></span></div><div><span style="color:#0090da;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2017, Micron filed a complaint against UMC and Jinhua in the U.S. District Court for the Northern District of California. The complaint alleges that UMC and Jinhua violated the Defend Trade Secrets Act, the civil provisions of the Racketeer Influenced and Corrupt Organizations Act, and California’s Uniform Trade Secrets Act by misappropriating Micron’s trade secrets and other misconduct. Micron’s complaint seeks damages, restitution, disgorgement of profits, injunctive relief, and other appropriate relief.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2019, current Micron employee, Chris Manning, filed a putative class action lawsuit on behalf of Micron employees subject to the Idaho Wage Claim Act who earned a performance-based bonus after the conclusion of 2018 whose performance rating was calculated based upon a mandatory percentage distribution range of performance ratings. On July 12, 2019, Manning and three other Company employees filed an amended complaint as putative class action representatives. On behalf of themselves and the putative class, Manning and the three other plaintiffs assert claims for violation of the Idaho Wage Claim Act, breach of contract, breach of the covenant of good faith and fair dealing, and fraud. On June 24, 2020, the court entered judgment in favor of Micron based on the statute of limitations, and the plaintiffs filed a notice of appeal on July 23, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, Micron and Intel entered into a binding arbitration agreement under which the parties agreed to present to an arbitral panel various financial disputes related to the IMFT joint venture between Micron and Intel, which ended October 31, 2019, and to other agreements relating to the joint development, production, and sale of non-volatile memory products. Each party alleges that the other owes damages relating to allegations of breach of one or more agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2015, Allied Telesis, Inc. and Allied Telesis International (Asia) Pte Ltd. filed a complaint against Micron in the Superior Court of California in Santa Clara alleging breach of implied and express warranties and fraudulent inducement to contract arising from plaintiffs’ purchase of certain allegedly defective DDR1 products between 2008 and 2010. Through subsequent amendments to the complaint, the plaintiffs substituted Allied Telesis K.K. as plaintiff, withdrew the warranty claims, and added claims of fraudulent concealment, negligent misrepresentation, negligence, and strict products liability. The plaintiff’s amended complaint seeks an unspecified award of damages, including punitive damages and lost profits. On September 3, 2020, the Superior Court granted summary judgment dismissing the claims for negligence and strict products liability and denied summary judgment as to the claims for negligent misrepresentation, fraudulent concealment, and fraudulent inducement to contract. No trial date has been set; however, trial is expected to occur in the first half of calendar 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify another party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to predict the outcome of the patent matters, Qimonda matter, antitrust matters, securities matter, binding arbitration with Intel, or any other matters noted above, and cannot make a reasonable estimate of the potential loss or range of possible losses. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.</span></div>We are currently a party to legal actions other than those described in this note arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition.
CY2020Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.061
CY2019Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.098
CY2019Q4	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-4000000	USD
CY2020Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	803000000	USD
CY2019Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	487000000	USD
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1115000000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1107000000	shares
CY2020Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	20000000	shares
CY2019Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	22000000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1135000000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1129000000	shares
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2020Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2019Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6000000	shares
CY2020Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5773000000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5144000000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	866000000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	518000000	USD

Files In Submission

Name	View Source	Status
0000723125-21-000012-index-headers.html	Edgar Link	pending
0000723125-21-000012-index.html	Edgar Link	pending
0000723125-21-000012.txt	Edgar Link	pending
0000723125-21-000012-xbrl.zip	Edgar Link	pending
a2021q1ex31-1xceocert.htm	Edgar Link	pending
a2021q1ex31-2xcfocert.htm	Edgar Link	pending
a2021q1ex32-1x906ceocert.htm	Edgar Link	pending
a2021q1ex32-2x906cfocert.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mu-20201203.htm	Edgar Link	pending
mu-20201203.xsd	Edgar Link	pending
mu-20201203_cal.xml	Edgar Link	unprocessable
mu-20201203_def.xml	Edgar Link	unprocessable
mu-20201203_g1.jpg	Edgar Link	pending
mu-20201203_g2.jpg	Edgar Link	pending
mu-20201203_g3.jpg	Edgar Link	pending
mu-20201203_htm.xml	Edgar Link	completed
mu-20201203_lab.xml	Edgar Link	unprocessable
mu-20201203_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MU
Micron Technology Inc Stock $mu

2020 Q4 Form 10-Q Financial Statement

#000072312521000012 Filed on January 08, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU Micron Technology Inc Stock $mu

2020 Q4 Form 10-Q Financial Statement

#000072312521000012 Filed on January 08, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU
Micron Technology Inc Stock $mu